DrugDashboards

Capecitabine

Capecitabine · CAPECITABINE 150 mg/1 · Tablet, Film Coated · Oral · Ascend Laboratories, LLC

NDC 67877-0458-12 · 120 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

17 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for capecitabine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA207652
TE code
AB
Approval date
Nov 24, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Capecitabine (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
BluePoint LaboratoriesCAPECITABINE 500 mg/1Jul 15, 2026Sep 3, 2026
BluePoint LaboratoriesCAPECITABINE 150 mg/1Jul 15, 2026Sep 3, 2026
Accord Healthcare Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Excella GmbH & Co. KGCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma, LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Teyro Labs Private LimitedCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teyro Labs Private LimitedCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Capecitabine — NDC 67877-0458-12," retrieved September 3, 2026, https://drugdashboards.com/drug/67877045812.

Free to cite with attribution — see how the data is put together.